Loading...
Header Logo
Keywords
Last Name
Institution

Professor Ali Khamesipour

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hosseini-Vasoukolaei N, Idali F, Khamesipour A, Yaghoobi-Ershadi MR, Kamhawi S, Valenzuela JG, Edalatkhah H, Arandian MH, Mirhendi H, Emami S, Jafari R, Saeidi Z, Jeddi-Tehrani M, Akhavan AA. Differential expression profiles of the salivary proteins SP15 and SP44 from Phlebotomus papatasi. Parasit Vectors. 2016 06 24; 9(1):357. PMID: 27342811.
      View in: PubMed
    2. Mobasheri M, Attar H, Rezayat Sorkhabadi SM, Khamesipour A, Jaafari MR. Solubilization Behavior of Polyene Antibiotics in Nanomicellar System: Insights from Molecular Dynamics Simulation of the Amphotericin B and Nystatin Interactions with Polysorbate 80. Molecules. 2015 Dec 24; 21(1):E6. PMID: 26712721.
      View in: PubMed
    3. Mehravaran A, Jaafari MR, Jalali SA, Khamesipour A, Tafaghodi M, Hojatizade M, Abbasi A, Badiee A. Cationic Immune Stimulating Complexes Containing Soluble Leishmania Antigens: Preparation, Characterization and in Vivo Immune Response Evaluation. Iran J Immunol. 2015 Dec; 12(4):274-87. PMID: 26714419.
      View in: PubMed
    4. Nateghi Rostami M, Seyyedan Jasbi E, Khamesipour A, Miramin Mohammadi A. Plasma levels of tumor necrosis factor-alpha (TNF-a), TNF-a soluble receptor type 1 (sTNFR I) and IL-22 in human leishmaniasis. Trop Biomed. 2015 Sep; 32(3):478-84. PMID: 26695208.
      View in: PubMed
    5. Mortazavi H, Hejazi P, Khamesipour A, Mohebali M, Ehsani AH, Mohammadi Y, Farahani IV, Amirzargar AA. Frequency of seropositivity against infectious agents amongst pemphigus vulgaris patients: a case-control study on Strongyloides stercoralis, Helicobacter pylori, Toxoplasma gondii, Leishmania major, and Epstein-Barr virus. Int J Dermatol. 2015 Nov; 54(11):e458-65. PMID: 26175264.
      View in: PubMed
    6. Azizi H, Kazemi B, Bandehpour M, Mohebali M, Khamesipour A, Aryaeipour M, Rokni MB. Molecular Cloning and Expression an 8-kDa Subunit of Antigen B from G1 strain of Echinococcus granulosus. Iran J Public Health. 2015 Jul; 44(7):962-8. PMID: 26576374.
      View in: PubMed
    7. Hosseini-Vasoukolaei N, Mahmoudi AR, Khamesipour A, Yaghoobi-Ershadi MR, Kamhawi S, Valenzuela JG, Arandian MH, Mirhendi H, Emami S, Saeidi Z, Idali F, Jafari R, Jeddi-Tehrani M, Akhavan AA. Seasonal and Physiological Variations of Phlebotomus papatasi Salivary Gland Antigens in Central Iran. J Arthropod Borne Dis. 2016 Mar; 10(1):39-49. PMID: 27047970.
      View in: PubMed
    8. Mamnoon B, Naserpour Farivar T, Kamyab AR, Ilghari D, Khamesipour A, Karimi Arzenani M. Quality Control of Widely Used Therapeutic Recombinant Proteins by a Novel Real-Time PCR Approach. Iran Biomed J. 2016; 20(1):56-62. PMID: 26047906.
      View in: PubMed
    9. Arjmand R, Fard SS, Saberi S, Tolouei S, Khamesipour A, Hejazi SH. Antigenic profile of heat-killed versus thimerosal-treated Leishmania major using sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Adv Biomed Res. 2015; 4:128. PMID: 26261830.
      View in: PubMed
    10. Mortazavi H, Mohebali M, Taslimi Y, Sadeghipour P, Ansari M, Kamyab K, Talebi M, Khamesipour A. Hoarseness as the Presenting Symptom of Visceral Leishmaniasis with Muco-Cutaneous Lesions: A Case Report. Iran J Parasitol. 2015 Apr-Jun; 10(2):296-300. PMID: 26246830.
      View in: PubMed
    11. Sharifi I, Aflatoonian MR, Fekri AR, Hakimi Parizi M, Aghaei Afshar A, Khosravi A, Sharifi F, Aflatoonian B, Khamesipour A, Dowlati Y, Modabber F, Nadim A. A comprehensive review of cutaneous leishmaniasis in kerman province, southeastern iran-narrative review article. Iran J Public Health. 2015 Mar; 44(3):299-307. PMID: 25905072.
      View in: PubMed
    12. Iman M, Davood A, Khamesipour A. Computational Study of Quinolone Derivatives to Improve their Therapeutic Index as Anti-malaria Agents: QSAR and QSTR. Iran J Pharm Res. 2015; 14(3):775-84. PMID: 26330866.
      View in: PubMed
    13. Khamesipour A. The need to teach vaccine safety to basic scientists and public health officials. Curr Drug Saf. 2015; 10(1):76-9. PMID: 25859679.
      View in: PubMed
    14. Ahmadi M, Fata A, Khamesipour A, Rakhshandeh H, Miramin Mohammadi A, Salehi G, Monavari H. The efficacy of hydro alcoholic extract of Seidlitzia rosmarinus on experimental zoonotic cutaneous leishmaniasis lesions in murine model. Avicenna J Phytomed. 2014 Nov; 4(6):385-91. PMID: 25386402.
      View in: PubMed
    15. Eskandari F, Talesh GA, Parooie M, Jaafari MR, Khamesipour A, Saberi Z, Abbasi A, Badiee A. Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis. Exp Parasitol. 2014 Nov; 146:78-86. PMID: 25246326.
      View in: PubMed
    16. Soleimanifard S, Arjmand R, Saberi S, Khamesipour A, Kazemi M, Salehi M, Akbari M, Hejazi S. P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER). Iran J Parasitol. 2014 Sep; 9(3):423-8. PMID: 25678928.
      View in: PubMed
    17. Anjomruz M, Oshaghi MA, Pourfatollah AA, Sedaghat MM, Raeisi A, Vatandoost H, Khamesipour A, Abai MR, Mohtarami F, Akbarzadeh K, Rafie F, Besharati M. Preferential feeding success of laboratory reared Anopheles stephensi mosquitoes according to ABO blood group status. Acta Trop. 2014 Dec; 140:118-23. PMID: 25151045.
      View in: PubMed
    18. Khamesipour A. Therapeutic vaccines for leishmaniasis. Expert Opin Biol Ther. 2014 Nov; 14(11):1641-9. PMID: 25077737.
      View in: PubMed
    19. Mortazavi H, Esmaili N, Khezri S, Khamesipour A, Vasheghani Farahani I, Daneshpazhooh M, Rezaei N. The effect of conventional immunosuppressive therapy on cytokine serum levels in pemphigus vulgaris patients. Iran J Allergy Asthma Immunol. 2014 Jun; 13(3):174-83. PMID: 24659121.
      View in: PubMed
    20. Davoudi N, Khamesipour A, Mahboudi F, McMaster WR. A dual drug sensitive L. major induces protection without lesion in C57BL/6 mice. PLoS Negl Trop Dis. 2014; 8(5):e2785. PMID: 24873970.
      View in: PubMed
    21. Kalat SA, Khamesipour A, Bavarsad N, Fallah M, Khashayarmanesh Z, Feizi E, Neghabi K, Abbasi A, Jaafari MR. Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice. Exp Parasitol. 2014 Aug; 143:5-10. PMID: 24780938.
      View in: PubMed
    22. Jabini R, Jaafari MR, Vahdati Hasani F, Ghazizadeh F, Khamesipour A, Karimi G. Effects of combined therapy with silymarin and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice. Drug Res (Stuttg). 2015 Mar; 65(3):119-24. PMID: 24623031.
      View in: PubMed
    23. Hoseini SG, Javanmard SH, Hejazi SH, Rafiei L, Zarkesh SH, Karbalaii K, Khamesipour A. Comparison of immune regulatory factors in acute and chronic lesions of cutaneous leishmaniasis due to Leishmania major. J Res Med Sci. 2014 Mar; 19(Suppl 1):S36-40. PMID: 25002892.
      View in: PubMed
    24. Aflatoonian MR, Sharifi I, Hakimi Parizi M, Fekri AR, Aflatoonian B, Sharifi M, Khosravi A, Khamesipour A, Sharifi H. A prospective cohort study of cutaneous leishmaniasis risk and opium addiction in south eastern Iran. PLoS One. 2014; 9(2):e89043. PMID: 24586494.
      View in: PubMed
    25. Mortazavi H, Soori T, Khamesipour A, Khatami A, Vasheghani-Farahani A. Co-existence of cutaneous leishmaniasis with pleural effusion: a case report from Iran. Acta Med Iran. 2014; 52(3):231-3. PMID: 24901728.
      View in: PubMed
    26. Kochhar S, Rath B, Seeber LD, Rundblad G, Khamesipour A, Ali M. Introducing new vaccines in developing countries. Expert Rev Vaccines. 2013 Dec; 12(12):1465-78. PMID: 24195483.
      View in: PubMed
    27. Tolouei S, Hejazi SH, Ghaedi K, Khamesipour A, Hasheminia SJ. TLR2 and TLR4 in cutaneous leishmaniasis caused by Leishmania major. Scand J Immunol. 2013 Nov; 78(5):478-84. PMID: 23980810.
      View in: PubMed
    28. Bakhshi H, Borhani N, Mohebali M, Khamesipour A, Abai MR, Hajjaran H, Tajedin L, Rassi Y, Akhavan AA, Mohtarami F, Oshaghi MA. Interleukin 4 (IL-4) gene promoter polymorphisms in Rhombomys opimus, the main reservoir of zoonotic cutaneous leishmaniasis. Cytokine. 2014 Jan; 65(1):1-3. PMID: 24209596.
      View in: PubMed
    29. Kheirandish F, Sharafi AC, Kazemi B, Bandehpour M, Tarahi Mj, Khamesipour A. First molecular identification of Leishmania species in a new endemic area of cutaneous leishmaniasis in Lorestan, Iran. Asian Pac J Trop Med. 2013 Sep; 6(9):713-7. PMID: 23827149.
      View in: PubMed
    30. Chavoshian O, Biari N, Badiee A, Khamesipour A, Abbasi A, Saberi Z, Jalali SA, Jaafari MR. Sphingomyelin Liposomes Containing Soluble Leishmania major antigens Induced Strong Th2 Immune Response in BALB/c Mice. Iran J Basic Med Sci. 2013 Sep; 16(9):965-72. PMID: 24171074.
      View in: PubMed
    31. Kazemi-Rad E, Mohebali M, Khadem-Erfan MB, Hajjaran H, Hadighi R, Khamesipour A, Rezaie S, Saffari M, Raoofian R, Heidari M. Overexpression of ubiquitin and amino acid permease genes in association with antimony resistance in Leishmania tropica field isolates. Korean J Parasitol. 2013 Aug; 51(4):413-9. PMID: 24039283.
      View in: PubMed
    32. Kazemi-Rad E, Mohebali M, Khadem-Erfan MB, Saffari M, Raoofian R, Hajjaran H, Hadighi R, Khamesipour A, Rezaie S, Abedkhojasteh H, Heidari M. Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach. Exp Parasitol. 2013 Oct; 135(2):344-9. PMID: 23928349.
      View in: PubMed
    33. Firouzmand H, Badiee A, Khamesipour A, Heravi Shargh V, Alavizadeh SH, Abbasi A, Jaafari MR. Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA). Acta Trop. 2013 Dec; 128(3):528-35. PMID: 23916506.
      View in: PubMed
    34. Rezaei Riabi T, Sharifi I, Miramin Mohammadi A, Khamesipour A, Hakimi Parizi M. Evaluation of a Possible Synergistic Effect of Meglumine Antimoniate with Paromomycin, Miltefosine or Allopurinol on in Vitro Susceptibility of Leishmania tropica Resistant Isolate. Iran J Parasitol. 2013 Jul; 8(3):396-401. PMID: 24454432.
      View in: PubMed
    35. Mohammadi AM, Khamesipour A, Khatami A, Javadi A, Nassiri-Kashani M, Firooz A, Dowlati Y, Behnia M, Eskandari SE. Cutaneous leishmaniasis in suspected patients referred to the center for research and training in skin diseases and leprosy, tehran, iran from 2008 to 2011. Iran J Parasitol. 2013 Jul; 8(3):430-6. PMID: 24454437.
      View in: PubMed
    36. Khatami A, Talaee R, Rahshenas M, Khamesipour A, Mehryan P, Tehrani S, Dowlati Y, Firooz A. Dressings combined with injection of meglumine antimoniate in the treatment of cutaneous leishmaniasis: a randomized controlled clinical trial. PLoS One. 2013; 8(6):e66123. PMID: 23826087.
      View in: PubMed
    37. Barati M, Mohebali M, Alimohammadian MH, Khamesipour A, Akhoundi B, Zarei Z. Canine visceral leishmaniasis: seroprevalence survey of asymptomatic dogs in an endemic area of northwestern Iran. J Parasit Dis. 2015 Jun; 39(2):221-4. PMID: 26064004.
      View in: PubMed
    38. Alvar J, Croft SL, Kaye P, Khamesipour A, Sundar S, Reed SG. Case study for a vaccine against leishmaniasis. Vaccine. 2013 Apr 18; 31 Suppl 2:B244-9. PMID: 23598489.
      View in: PubMed
    39. Kheirandish F, Bandehpour M, Davoudi N, Mosaffa N, Dawood S, Kazemi B, Haghighi A, Khamesipour A, Masjedi H, Mohebali M, Mahboudi F. Gene regulation of pteridine reductase 1 in leishmania promastigotes and amastigotes using a full-length antisense construct. Iran J Parasitol. 2013 Apr; 8(2):190-6. PMID: 23914230.
      View in: PubMed
    40. Bonhoeffer J, Imoukhuede EB, Aldrovandi G, Bachtiar NS, Chan ES, Chang S, Chen RT, Fernandopulle R, Goldenthal KL, Heffelfinger JD, Hossain S, Jevaji I, Khamesipour A, Kochhar S, Makhene M, Malkin E, Nalin D, Prevots R, Ramasamy R, Sellers S, Vekemans J, Walker KB, Wilson P, Wong V, Zaman K, Heininger U. Template protocol for clinical trials investigating vaccines--focus on safety elements. Vaccine. 2013 Nov 12; 31(47):5602-20. PMID: 23499603.
      View in: PubMed
    41. Askari N, Vaez-Mahdavi MR, Moaiedmohseni S, Khamesipour A, Soroush MR, Moin A, Jalaie S, Ghazanfari Z, Faghihzadeh E, Ghazanfari T. Association of chemokines and prolactin with cherry angioma in a sulfur mustard exposed population--Sardasht-Iran cohort study. Int Immunopharmacol. 2013 Nov; 17(3):991-5. PMID: 23370299.
      View in: PubMed
    42. Yarmohammadi ME, Hassan ZM, Mostafaie A, Ebtekar M, Yaraee R, Pourfarzam S, Jalali-Nadoushan M, Faghihzadeh S, Vaez-Mahdavi MR, Soroush MR, Khamesipour A, Faghihzadeh E, Sharifnia Z, Naghizadeh MM, Ghazanfari T. Salivary levels of secretary IgA, C5a and alpha 1-antitrypsin in sulfur mustard exposed patients 20 years after the exposure, Sardasht-Iran Cohort Study (SICS). Int Immunopharmacol. 2013 Nov; 17(3):952-7. PMID: 23375936.
      View in: PubMed
    43. Ghasemi H, Mostafaie A, Yaraee R, Hassan ZM, Rezaei A, Mahmoudi M, Faghihzadeh S, Soroush MR, Ardestani SK, Babaei M, Jalali-Nadoushan M, Khamesipour A, Ghassemi-Broumand M, Ghazanfari T. Association of serum immunoglobulins levels and eye injuries in sulfur mustard exposed: Sardasht-Iran Cohort Study. Int Immunopharmacol. 2013 Nov; 17(3):944-51. PMID: 23370295.
      View in: PubMed
    44. Moin A, Khamesipour A, Hassan ZM, Ebtekar M, Davoudi SM, Vaez-Mahdavi MR, Soroush MR, Faghihzadeh S, Naghizadeh MM, Ghazanfari T. Pro-inflammatory cytokines among individuals with skin findings long-term after sulfur mustard exposure: Sardasht-Iran Cohort Study. Int Immunopharmacol. 2013 Nov; 17(3):986-90. PMID: 23370294.
      View in: PubMed
    45. Eslami G, Anvarii H, Ebadi M, Nabipour Y, Mirzaei F, Gholamrezaei M, Khamesipour A. The changing profile of cutaneous leishmaniasis agent in a central province of Iran. Tanzan J Health Res. 2013 Jan; 15(1):33-9. PMID: 26591671.
      View in: PubMed
    46. Badiee A, Heravi Shargh V, Khamesipour A, Jaafari MR. Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends. Vaccine. 2013 Jan 21; 31(5):735-49. PMID: 23219436.
      View in: PubMed
    47. Rath B, Ali M, Elemuwa C, Maurer W, Bouder F, Mworozi E, Diedrich S, Khamesipour A, Chitwood I, Kochhar S. Prioritizing polio. Expert Rev Vaccines. 2012 Dec; 11(12):1389-92. PMID: 23252381.
      View in: PubMed
    48. Khamesipour A, Jafari Shakib R. One swallow doesn’t bring spring. Response to letter to editor. Transfus Apher Sci. 2012 Dec; 47(3):371. PMID: 22999644.
      View in: PubMed
    49. Keshavarz Valian H, Nateghi Rostami M, Tasbihi M, Miramin Mohammadi A, Eskandari SE, Sarrafnejad A, Khamesipour A. CCR7+ central and CCR7- effector memory CD4+ T cells in human cutaneous leishmaniasis. J Clin Immunol. 2013 Jan; 33(1):220-34. PMID: 22990666.
      View in: PubMed
    50. Badiee A, Khamesipour A, Samiei A, Soroush D, Shargh VH, Kheiri MT, Barkhordari F, Robert Mc Master W, Mahboudi F, Jaafari MR. The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen. Exp Parasitol. 2012 Dec; 132(4):403-9. PMID: 22982807.
      View in: PubMed
    51. Latifynia A, Khamesipour A, Bokaie S, Khansari N. Antioxidants and proinflamatory cytokines in the sera of patients with cutaneous leishmaniasis. Iran J Immunol. 2012 Sep; 9(3):208-14. PMID: 23023385.
      View in: PubMed
    52. Golali E, Jaafari MR, Khamesipour A, Abbasi A, Saberi Z, Badiee A. Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model. Iran J Basic Med Sci. 2012 Sep; 15(5):1032-45. PMID: 23493437.
      View in: PubMed
    53. Eskandari S, Azimzadeh A, Bahar M, Naraghi ZS, Javadi A, Khamesipour A, Mohamadi AM. Efficacy of Microwave and Infrared Radiation in the Treatment of the Skin Lesions Caused by Leishmania major in an Animal Model. Iran J Public Health. 2012; 41(8):80-3. PMID: 23113229.
      View in: PubMed
    54. Alavizadeh SH, Badiee A, Khamesipour A, Jalali SA, Firouzmand H, Abbasi A, Jaafari MR. The role of liposome-protamine-DNA nanoparticles containing CpG oligodeoxynucleotides in the course of infection induced by Leishmania major in BALB/c mice. Exp Parasitol. 2012 Nov; 132(3):313-9. PMID: 22819791.
      View in: PubMed
    55. Bavarsad N, Fazly Bazzaz BS, Khamesipour A, Jaafari MR. Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice. Acta Trop. 2012 Oct; 124(1):33-41. PMID: 22750480.
      View in: PubMed
    56. Hoseini SG, Javanmard SH, Zarkesh SH, Khamesipour A, Rafiei L, Karbalaie K, Nilforoushzade M, Baghaei M, Hejazi SH. Regulatory T-cell profile in early and late lesions of cutaneous leishmaniasis due to Leishmania major. J Res Med Sci. 2012 Jun; 17(6):513-8. PMID: 23626625.
      View in: PubMed
    57. Rath B, Ali M, Codarini G, Elemuwa C, Khamesipour A, Maurer W, Mworozi E, Rundblad G, Varughese S, Kochhar S. Promoting evidence-based vaccine safety research and communication--the Vienna Vaccine Safety Initiative. J Trop Pediatr. 2012 Jun; 58(3):167-9. PMID: 22659838.
      View in: PubMed
    58. Shargh VH, Jaafari MR, Khamesipour A, Jaafari I, Jalali SA, Abbasi A, Badiee A. Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis. Vaccine. 2012 Jun 06; 30(26):3957-64. PMID: 22465747.
      View in: PubMed
    59. Muehlhans S, Richard G, Ali M, Codarini G, Elemuwa C, Khamesipour A, Maurer W, Mworozi E, Kochhar S, Rundblad G, Vuitton D, Rath B. Safety reporting in developing country vaccine clinical trials-a systematic review. Vaccine. 2012 May 09; 30(22):3255-65. PMID: 22406279.
      View in: PubMed
    60. Khamesipour A, Abbasi A, Firooz A, Mohammadi AM, Eskandari SE, Jaafari MR. Treatment of cutaneous lesion of 20 years' duration caused by leishmanization. Indian J Dermatol. 2012 Mar; 57(2):123-5. PMID: 22615509.
      View in: PubMed
    61. Khamesipour A, Nateghi Rostami M, Tasbihi M, Miramin Mohammadi A, Shahrestani T, Sarrafnejad A, Sohrabi Y, Eskandari SE, Keshavarz Valian H. Phenotyping of circulating CD8? T cell subsets in human cutaneous leishmaniasis. Microbes Infect. 2012 Aug; 14(9):702-11. PMID: 22421108.
      View in: PubMed
    62. Heravi Shargh V, Jaafari MR, Khamesipour A, Jalali SA, Firouzmand H, Abbasi A, Badiee A. Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis. Parasitol Res. 2012 Jul; 111(1):105-14. PMID: 22223037.
      View in: PubMed
    63. Hejazi Sh, Hoseini S, Javanmard Sh, Zarkesh Sh, Khamesipour A. Interleukin-10 and Transforming Growth Factor-ß in Early and Late Lesions of Patients with Leishmania major induced Cutaneous Leishmaniasis. Iran J Parasitol. 2012; 7(2):53-60. PMID: 23109946.
      View in: PubMed
    64. Hejazi Sh, Hoseini S, Javanmard Sh, Zarkesh Sh, Khamesipour A. Interleukin-10 and Transforming Growth Factor-ß in Early and Late Lesions of Patients with Leishmania major Induced Cutaneous Leishmaniasis. Iran J Parasitol. 2012; 7(3):16-23. PMID: 23109957.
      View in: PubMed
    65. Tolouei S, Ghaedi K, Khamesipour A, Akbari M, Baghaei M, Hasheminia S, Narimani M, Hejazi Sh. IL-23 and IL-27 Levels in Macrophages Collected from Peripheral Blood of Patients with Healing Vs Non-Healing Form of Cutaneous Leishmaniasis. Iran J Parasitol. 2012; 7(1):18-25. PMID: 23133467.
      View in: PubMed
    66. Akhavan A, Ghods R, Jeddi-Tehrani M, Yaghoobi-Ershadi M, Khamesipour A, Mahmoudi A. Production and Purification of Anti-Rhombomys opimus Immunoglobulins. Iran J Arthropod Borne Dis. 2011; 5(2):69-76. PMID: 22808420.
      View in: PubMed
    67. Pardakhty A, Shakibaie M, Daneshvar H, Khamesipour A, Mohammadi-Khorsand T, Forootanfar H. Preparation and evaluation of niosomes containing autoclaved Leishmania major: a preliminary study. J Microencapsul. 2012; 29(3):219-24. PMID: 22150018.
      View in: PubMed
    68. Khamesipour A, Amiri ZM, Kafiabad SA, Saadat F, Mansour-ghanaei F, Esteghamati AR, Shakib RJ. Frequency of hepatitis B virus DNA in anti-HBc positive, HBsAg negative blood donors in Rasht, northern Iran. Transfus Apher Sci. 2011 Oct; 45(2):195-7. PMID: 21971311.
      View in: PubMed
    69. Shokri A, Sharifi I, Khamesipour A, Nakhaee N, Fasihi Harandi M, Nosratabadi J, Hakimi Parizi M, Barati M. The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate. Parasitol Res. 2012 Mar; 110(3):1113-7. PMID: 21847598.
      View in: PubMed
    70. Tolouei S, Hasheminia S, Narimani M, Khamesipour A, Shatalebi M, Hejazi Sh. Leishmanicidal Activity of Films Containing Paromomycin and Gentamicin Sulfate both In Vitro and In Vivo. Iran J Parasitol. 2011 Aug; 6(3):60-5. PMID: 22347298.
      View in: PubMed
    71. Tafaghodi M, Eskandari M, Khamesipour A, Jaafari MR. Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis. Exp Parasitol. 2011 Oct; 129(2):107-14. PMID: 21767536.
      View in: PubMed
    72. Sharifi I, Nakhaei N, Aflatoonian M, Parizi MH, Fekri A, Safizadeh H, Shirzadi M, Gooya M, Khamesipour A, Nadim A. Cutaneous leishmaniasis in bam: a comparative evaluation of pre- and post-earthquake years (1999-2008). Iran J Public Health. 2011; 40(2):49-56. PMID: 23113072.
      View in: PubMed
    73. Sharifi I, Poursmaelian S, Aflatoonian MR, Ardakani RF, Mirzaei M, Fekri AR, Khamesipour A, Parizi MH, Harandi MF. Emergence of a new focus of anthroponotic cutaneous leishmaniasis due to Leishmania tropica in rural communities of Bam district after the earthquake, Iran. Trop Med Int Health. 2011 Apr; 16(4):510-3. PMID: 21255206.
      View in: PubMed
    74. Tafaghodi M, Khamesipour A, Jaafari MR. Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN. Parasitol Res. 2011 May; 108(5):1265-73. PMID: 21125294.
      View in: PubMed
    75. Tafaghodi M, Eskandari M, Kharazizadeh M, Khamesipour A, Jaafari MR. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins. Trop Biomed. 2010 Dec; 27(3):639-50. PMID: 21399606.
      View in: PubMed
    76. Eslami G, Frikha F, Salehi R, Khamesipour A, Hejazi H, Nilforoushzadeh MA. Cloning, expression and dynamic simulation of TRYP6 from Leishmania major (MRHO/IR/75/ER). Mol Biol Rep. 2011 Aug; 38(6):3765-76. PMID: 21120619.
      View in: PubMed
    77. Nateghi Rostami M, Keshavarz H, Edalat R, Sarrafnejad A, Shahrestani T, Mahboudi F, Khamesipour A. CD8+ T cells as a source of IFN-? production in human cutaneous leishmaniasis. PLoS Negl Trop Dis. 2010 Oct 12; 4(10):e845. PMID: 20967288.
      View in: PubMed
    78. Akhavan AA, Mirhendi H, Khamesipour A, Alimohammadian MH, Rassi Y, Bates P, Kamhawi S, Valenzuela JG, Arandian MH, Abdoli H, Jalali-zand N, Jafari R, Shareghi N, Ghanei M, Yaghoobi-Ershadi MR. Leishmania species: detection and identification by nested PCR assay from skin samples of rodent reservoirs. Exp Parasitol. 2010 Dec; 126(4):552-6. PMID: 20566364.
      View in: PubMed
    79. Akhavan AA, Yaghoobi-Ershadi MR, Khamesipour A, Mirhendi H, Alimohammadian MH, Rassi Y, Arandian MH, Jafari R, Abdoli H, Shareghi N, Ghanei M, Jalali-zand N. Dynamics of Leishmania infection rates in Rhombomys opimus (Rodentia: Gerbillinae) population of an endemic focus of zoonotic cutaneous leishmaniasis in Iran. Bull Soc Pathol Exot. 2010 May; 103(2):84-9. PMID: 20390397.
      View in: PubMed
    80. Sharifi I, Fekri AR, Aflatoonian MR, Khamesipour A, Mahboudi F, Dowlati Y, Nadim A, Modabber F. Leishmaniasis recidivans among school children in Bam, South-east Iran, 1994-2006. Int J Dermatol. 2010 May; 49(5):557-61. PMID: 20534092.
      View in: PubMed
    81. Nateghi Rostami M, Keshavarz H, Khamesipour A. Immune response of BALB/c mice against an experimental vaccine of Alum precipitated autoclaved Leishmania major (Alum-ALM) mixed with BCG or Mycobacterium vaccae. Trop Biomed. 2010 Apr; 27(1):89-102. PMID: 20562818.
      View in: PubMed
    82. Akhavan A, Yaghoobi-Ershadi M, Mirhendi H, Alimohammadian M, Rassi Y, Shareghi N, Jafari R, Arandian M, Abdoli H, Ghanei M, Jalali-Zand N, Khamesipour A. Molecular epizootiology of rodent leishmaniasis in a hyperendemic area of iran. Iran J Public Health. 2010; 39(1):1-7. PMID: 23112983.
      View in: PubMed
    83. Hejazi H, Tasbihi M, Jaafari M, Badiee A, Pestechian N, Javadi A, Khamesipour A. The Role of Liposomal CpG ODN on the Course of L. major Infection in BALB/C Mice. Iran J Parasitol. 2010 Mar; 5(1):47-54. PMID: 22347235.
      View in: PubMed
    84. Nateghi Rostami M, Keshavarz Valian H, Eskandari SE, Miramin Mohammadi A, Shahrestani ST, Sarraf-Nejad A, Khamesipour A. Differential in vitro CD4+/CD8+ T-cell response to live vs. killed Leishmania major. Parasite Immunol. 2010 Feb; 32(2):101-10. PMID: 20070824.
      View in: PubMed
    85. Monot M, Honoré N, Garnier T, Zidane N, Sherafi D, Paniz-Mondolfi A, Matsuoka M, Taylor GM, Donoghue HD, Bouwman A, Mays S, Watson C, Lockwood D, Khamesipour A, Khamispour A, Dowlati Y, Jianping S, Rea TH, Vera-Cabrera L, Stefani MM, Banu S, Macdonald M, Sapkota BR, Spencer JS, Thomas J, Harshman K, Singh P, Busso P, Gattiker A, Rougemont J, Brennan PJ, Cole ST. Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat Genet. 2009 Dec; 41(12):1282-9. PMID: 19881526.
      View in: PubMed
    86. Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F. Enhancement of immune response and protection in BALB/c mice immunized with liposomal recombinant major surface glycoprotein of Leishmania (rgp63): the role of bilayer composition. Colloids Surf B Biointerfaces. 2009 Nov 01; 74(1):37-44. PMID: 19615870.
      View in: PubMed
    87. Noazin S, Khamesipour A, Moulton LH, Tanner M, Nasseri K, Modabber F, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Smith PG. Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis. Vaccine. 2009 Jul 30; 27(35):4747-53. PMID: 19540273.
      View in: PubMed
    88. Jaafari MR, Bavarsad N, Bazzaz BS, Samiei A, Soroush D, Ghorbani S, Heravi MM, Khamesipour A. Effect of topical liposomes containing paromomycin sulfate in the course of Leishmania major infection in susceptible BALB/c mice. Antimicrob Agents Chemother. 2009 Jun; 53(6):2259-65. PMID: 19223613.
      View in: PubMed
    89. Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F. The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63). Exp Parasitol. 2009 Apr; 121(4):362-9. PMID: 19211022.
      View in: PubMed
    90. Noazin S, Modabber F, Khamesipour A, Smith PG, Moulton LH, Nasseri K, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Kieny MP, Tanner M. First generation leishmaniasis vaccines: a review of field efficacy trials. Vaccine. 2008 Dec 09; 26(52):6759-67. PMID: 18950671.
      View in: PubMed
    91. Jafari-Shakib R, Shokrgozar MA, Nassiri-Kashani M, Malakafzali B, Nikbin B, Khamesipour A. Plasma sCD26 and sCD30 levels in cutaneous leishmaniasis. Acta Trop. 2009 Jan; 109(1):61-3. PMID: 18983807.
      View in: PubMed
    92. Lieke T, Nylén S, Eidsmo L, McMaster WR, Mohammadi AM, Khamesipour A, Berg L, Akuffo H. Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation. Clin Exp Immunol. 2008 Aug; 153(2):221-30. PMID: 18713141.
      View in: PubMed
    93. Keshavarz Valian H, Khoshabe Abdollah Kenedy L, Nateghi Rostami M, Miramin Mohammadi A, Khamesipour A. Role of Mycobacterium vaccae in the protection induced by first generation Leishmania vaccine against murine model of leishmaniasis. Parasitol Res. 2008 Jun; 103(1):21-8. PMID: 18317808.
      View in: PubMed
    94. Jafari-Shakib R, Ajdary S, Amiri ZM, Mohammadi AM, Nourijelyani K, Mortazavi H, Shokrgozar MA, Nikbin B, Khamesipour A. CD26 expression on CD4+T cells in patients with cutaneous leishmaniasis. Clin Exp Immunol. 2008 Jul; 153(1):31-6. PMID: 18460019.
      View in: PubMed
    95. Badiee A, Jaafari MR, Samiei A, Soroush D, Khamesipour A. Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice. Clin Vaccine Immunol. 2008 Apr; 15(4):668-74. PMID: 18235040.
      View in: PubMed
    96. Daneshpazhooh M, Chams-Davatchi C, Khamesipour A, Mansoori P, Taheri A, Firooz A, Mortazavi H, Esmaili N, Dowlati Y. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity. J Eur Acad Dermatol Venereol. 2007 Nov; 21(10):1319-24. PMID: 17958835.
      View in: PubMed
    97. Kashani MN, Firooz A, Eskandari SE, Ghoorchi MH, Khamesipour A, Khatami A, Javadi A, Dowlati Y. Evaluation of meglumine antimoniate effects on liver, kidney and pancreas function tests in patients with cutaneous leishmaniasis. Eur J Dermatol. 2007 Nov-Dec; 17(6):513-5. PMID: 17951131.
      View in: PubMed
    98. Hadighi R, Boucher P, Khamesipour A, Meamar AR, Roy G, Ouellette M, Mohebali M. Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs. Parasitol Res. 2007 Oct; 101(5):1319-22. PMID: 17610079.
      View in: PubMed
    99. Jaafari MR, Badiee A, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F. The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome. Vaccine. 2007 Aug 10; 25(32):6107-17. PMID: 17629372.
      View in: PubMed
    100. Rüggeberg JU, Gold MS, Bayas JM, Blum MD, Bonhoeffer J, Friedlander S, de Souza Brito G, Heininger U, Imoukhuede B, Khamesipour A, Erlewyn-Lajeunesse M, Martin S, Mäkelä M, Nell P, Pool V, Simpson N. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2007 Aug 01; 25(31):5675-84. PMID: 17448577.
      View in: PubMed
    101. Ajdary S, Jafari-Shakib R, Riazi-Rad F, Khamesipour A. Soluble CD26 and CD30 levels in patients with anthroponotic cutaneous leishmaniasis. J Infect. 2007 Jul; 55(1):75-8. PMID: 17241668.
      View in: PubMed
    102. Alimohammadian MH, Darabi H, Malekzadeh S, Mahmoodzadeh-Niknam H, Ajdary S, Khamesipour A, Bahonar A, Mofarrah A. Exposure to Leishmania major modulates the proportion of CD4+ T cells without affecting cellular immune responses. Microbiol Immunol. 2007; 51(10):1003-11. PMID: 17951990.
      View in: PubMed
    103. Firooz A, Khamesipour A, Ghoorchi MH, Nassiri-Kashani M, Eskandari SE, Khatami A, Hooshmand B, Gorouhi F, Rashighi-Firoozabadi M, Dowlati Y. Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial. Arch Dermatol. 2006 Dec; 142(12):1575-9. PMID: 17178983.
      View in: PubMed
    104. Badiee A, Jaafari MR, Khamesipour A. Leishmania major: immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes. Exp Parasitol. 2007 Feb; 115(2):127-34. PMID: 16979165.
      View in: PubMed
    105. Nylén S, Khamesipour A, Mohammadi A, Jafari-Shakib R, Eidsmo L, Noazin S, Modabber F, Akuffo H. Surrogate markers of immunity to Leishmania major in leishmanin skin test negative individuals from an endemic area re-visited. Vaccine. 2006 Nov 17; 24(47-48):6944-54. PMID: 17049693.
      View in: PubMed
    106. Jaafari MR, Ghafarian A, Farrokh-Gisour A, Samiei A, Kheiri MT, Mahboudi F, Barkhordari F, Khamesipour A, McMaster WR. Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice. Vaccine. 2006 Jul 17; 24(29-30):5708-17. PMID: 16740346.
      View in: PubMed
    107. Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M. Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med. 2006 May; 3(5):e162. PMID: 16605301.
      View in: PubMed
    108. Khamesipour A, Rafati S, Davoudi N, Maboudi F, Modabber F. Leishmaniasis vaccine candidates for development: a global overview. Indian J Med Res. 2006 Mar; 123(3):423-38. PMID: 16778321.
      View in: PubMed
    109. Ghazanfari T, Hassan ZM, Khamesipour A. Enhancement of peritoneal macrophage phagocytic activity against Leishmania major by garlic (Allium sativum) treatment. J Ethnopharmacol. 2006 Feb 20; 103(3):333-7. PMID: 16213117.
      View in: PubMed
    110. Khamesipour A, Dowlati Y, Asilian A, Hashemi-Fesharki R, Javadi A, Noazin S, Modabber F. Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis. Vaccine. 2005 May 25; 23(28):3642-8. PMID: 15882524.
      View in: PubMed
    111. Eidsmo L, Nylen S, Khamesipour A, Hedblad MA, Chiodi F, Akuffo H. The contribution of the Fas/FasL apoptotic pathway in ulcer formation during Leishmania major-induced cutaneous Leishmaniasis. Am J Pathol. 2005 Apr; 166(4):1099-108. PMID: 15793290.
      View in: PubMed
    112. Shazad B, Abbaszadeh B, Khamesipour A. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major. Eur J Dermatol. 2005 Mar-Apr; 15(2):85-7. PMID: 15757817.
      View in: PubMed
    113. Firooz A, Khatami A, Khamesipour A, Nassiri-Kashani M, Behnia F, Nilforoushzadeh M, Pazoki-Toroudi H, Dowlati Y. Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: a randomized, double-blind, controlled clinical trial. J Drugs Dermatol. 2005 Jan-Feb; 4(1):73-9. PMID: 15696988.
      View in: PubMed
    114. Nassiri-Kashani M, Firooz A, Khamesipour A, Mojtahed F, Nilforoushzadeh M, Hejazi H, Bouzari N, Dowlati Y. A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis. J Eur Acad Dermatol Venereol. 2005 Jan; 19(1):80-3. PMID: 15649196.
      View in: PubMed
    115. Mohebali M, Khamesipour A, Mobedi I, Zarei Z, Hashemi-Fesharki R. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran. Vaccine. 2004 Sep 28; 22(29-30):4097-100. PMID: 15364462.
      View in: PubMed
    116. Mahmoodi M, Khamesipour A, Dowlati Y, Rafati S, Momeni AZ, Emamjomeh M, Hejazi H, Modabber F. Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG. Clin Exp Immunol. 2003 Nov; 134(2):303-8. PMID: 14616791.
      View in: PubMed
    117. Mousavi MR, Damghani MA, Haghdoust AA, Khamesipour A. Opium and risk of laryngeal cancer. Laryngoscope. 2003 Nov; 113(11):1939-43. PMID: 14603052.
      View in: PubMed
    118. Firooz A, Khamesipour A, Dowlati Y. Itraconazole pulse therapy improves the quality of life of patients with toenail onychomycosis. J Dermatolog Treat. 2003 Jun; 14(2):95-8. PMID: 12775316.
      View in: PubMed
    119. Alimohammadian MH, Khamesipour A, Darabi H, Firooz A, Malekzadeh S, Bahonar A, Dowlati Y, Modabber F. The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis. Vaccine. 2002 Dec 13; 21(3-4):174-80. PMID: 12450691.
      View in: PubMed
    120. Habibi GR, Khamesipour A, McMaster WR, Mahboudi F. Cytokine gene expression in healing and non-healing cases of cutaneous leishmaniasis in response to in vitro stimulation with recombinant gp63 using semi-quantitative RT-PCR. Scand J Immunol. 2001 Oct; 54(4):414-20. PMID: 11555409.
      View in: PubMed
    121. Momeni AZ, Jalayer T, Emamjomeh M, Khamesipour A, Zicker F, Ghassemi RL, Dowlati Y, Sharifi I, Aminjavaheri M, Shafiei A, Alimohammadian MH, Hashemi-Fesharki R, Nasseri K, Godal T, Smith PG, Modabber F. A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran. Vaccine. 1999 Feb 05; 17(5):466-72. PMID: 10073725.
      View in: PubMed
    122. Dowlati B, Firooz A, Khamesipour A, Lotfi M, Stuart CA, Smith EB, Larijani B, Dowlati Y. Insulin quantification in patients with seborrheic dermatitis. Arch Dermatol. 1998 Aug; 134(8):1043-5. PMID: 9722747.
      View in: PubMed
    123. Sharifi I, FeKri AR, Aflatonian MR, Khamesipour A, Nadim A, Mousavi MR, Momeni AZ, Dowlati Y, Godal T, Zicker F, Smith PG, Modabber F. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet. 1998 May 23; 351(9115):1540-3. PMID: 10326536.
      View in: PubMed
    124. Bahar K, Dowlati Y, Shidani B, Alimohammadian MH, Khamesipour A, Ehsasi S, Hashemi-Fesharki R, Ale-Agha S, Modabber F. Comparative safety and immunogenicity trial of two killed Leishmania major vaccines with or without BCG in human volunteers. Clin Dermatol. 1996 Sep-Oct; 14(5):489-95. PMID: 8889326.
      View in: PubMed
    125. Khamesipour A, Moticka EJ, Cooper MD. The effect of T-cell mitogens and cytokines on the infectivity of human fallopian tube mucosa by Chlamydia trachomatis. Adv Exp Med Biol. 1995; 371B:987-90. PMID: 7502942.
      View in: PubMed
    126. Khamesipour A, Pal S, Peterson EM, de la Maza LM. Induction of infertility by the Chlamydia trachomatis mouse pneumonitis biovar in strains of mice that differ in their response to the 60 kDa heat shock protein. J Reprod Fertil. 1994 Jul; 101(2):287-94. PMID: 7932361.
      View in: PubMed
    127. de la Maza LM, Pal S, Khamesipour A, Peterson EM. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun. 1994 May; 62(5):2094-7. PMID: 8168974.
      View in: PubMed
    Khamesipour's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description